539 related articles for article (PubMed ID: 11000734)
1. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Yang JC; Yang KC; Hsu CT; Wang CS; Kuo CF; Wang TH
J Microbiol Immunol Infect; 1999 Mar; 32(1):1-8. PubMed ID: 11561564
[TBL] [Abstract][Full Text] [Related]
3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
5. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
6. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
7. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
8. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
9. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
10. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
[TBL] [Abstract][Full Text] [Related]
11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
13. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
[TBL] [Abstract][Full Text] [Related]
14. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
15. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
Huang WH; Ho AS; Shyu RY; Lee SC; Lee MM; Hsu CT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):448-55. PubMed ID: 9745160
[TBL] [Abstract][Full Text] [Related]
16. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
Prasertpetmanee S; Mahachai V; Vilaichone RK
Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
[TBL] [Abstract][Full Text] [Related]
18. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
20. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Poon SK; Chang CS; Su J; Lai CH; Yang CC; Chen GH; Wang WC
Aliment Pharmacol Ther; 2002 Feb; 16(2):291-6. PubMed ID: 11860412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
